ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ASCO® 2023 Insights: "Short-HER Data on Nine-Weeks vs. One-Year Trastuzumab in Early Stage HER2+ BC"
By
ecancer
FEATURING
Pierfranco Conte
By
ecancer
FEATURING
Pierfranco Conte
Login to view comments.
Click here to Login
